Samuel Z. Goldhaber

Internal Medicine · 2003–2020

A researcher in the Science corpus: 17 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Samuel Z. Goldhaber trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Heit

Papers from Samuel Z. Goldhaber's perspective

Ordered by how strongly the researchers Samuel Z. Goldhaber trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. (Circulation)
  2. Fibrinolysis for patients with intermediate-risk pulmonary embolism. (New England Journal of Medicine)
  3. Oral apixaban for the treatment of acute venous thromboembolism. (New England Journal of Medicine)
  4. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. (New England Journal of Medicine)
  5. Oral rivaroxaban for symptomatic venous thromboembolism. (New England Journal of Medicine)
  6. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) (European Respiratory Journal)
  7. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 (Thrombosis Research)
  8. Emergency hospitalizations for adverse drug events in older Americans. (New England Journal of Medicine)
  9. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy (Journal of Thrombosis and Haemostasis)
  10. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. (Blood Advances)

Their papers